Redefining KRAS activation

Nat Rev Clin Oncol. 2018 Sep;15(9):532. doi: 10.1038/s41571-018-0068-1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Afatinib*
  • Carcinogenesis
  • Cell Transformation, Neoplastic
  • Humans
  • Proto-Oncogene Proteins p21(ras)*

Substances

  • KRAS protein, human
  • Afatinib
  • Proto-Oncogene Proteins p21(ras)